Zimmer Biomet rises after Q4 earnings beat

Zimmer Biomet Holdings

10/02/2026 14:08

** Shares of medical device maker Zimmer Biomet Holdings ZBH.N rise 1.68% to $91.24 premarket

** Co reports Q4 revenue of $2.24 billion vs. analysts' estimates of $2.23 billion - data compiled by LSEG

** Reports Q4 adj. profit of $2.42 per share, compared to estimates of $2.4 per share

** Projects 2026 adj. profit per share in range of $8.3 to $8.45

** ZBH stock fell 14.87% in 2025

(Reporting by Gnaneshwar Rajan in Bengaluru)

((Gnaneshwar.Rajan@thomsonreuters.com;))